The FDA's Pharmacy Compounding Advisory Committee (PCAC) is scheduled to review TB-500 in July 2026 for possible placement on the 503A Bulks List (Category 1)
Mekki K, Bouzidi-bekada N, Kaddous A, Bouchenak M
For compounded tirzepatide: Monthly: $299 per month (billed separately) 3-month plan: $249 per month 6-month plan: $229 per month For compounded tirzepatide microdoses: Monthly: $199 per month (billed separately) For compounded semaglutide: Monthly: $299 per month (billed separately) 3-month plan: $249 per month For compounded semaglutide microdoses: Monthly: $199 per month (billed separately) Other medications, such as Metformin ($90/3 months), Ozempic ($1,199/month) and Wegovy ($1,599/month), are also billed separately and are not included in the membership plans
However, there is no clear evidence for a functional significant dopamine release in the pineal gland, where the catecholaminergic input is largely noradrenergic, the noradrenergic afferents from the superior cervical ganglion (33, 34)